Kenvue Inc. Common Stock (KVUE)
Stock · NYSE · Consumer Discretionary
$18.9as of 10/16/2026
Price chart
Active signals
KVUE Signal Track Record
How signals performed across all stocks →What KVUE's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.
| Signal | Times | Median 20-session return | Higher after 20 sessions | Last signal |
|---|---|---|---|---|
| Volume Spike | 20 | -1.3% | 40% | September 10, 2026 |
| Bollinger Band Breakdown | 14 | +4.9% | 64% | September 8, 2026 |
| 200-Day Moving Average TouchActive now | 13 | -2.7% | 23% | September 25, 2026 |
| Bollinger Band BreakoutActive now | 13 | +2.3% | 54% | July 2, 2026 |
| Any 20-session window (baseline) | +0.2% | 50% |
Computed by MarketWall from daily closing prices since February 20, 2024. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.
About KVUE
Kenvue Inc. operates as a consumer health company in the United States, rest of North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates in three segments: Self Care, Skin Health and Beauty, and Essential Health. The company offers over-the-counter medicine for cough, cold and allergy, pain care, digestive health, smoking cessation, and eye care, as well as other naturally insp…
- Sector
- Consumer Discretionary
- Industry
- Package Goods/Cosmetics
- Employees
- 21,780
- Website
- www.kenvue.com
Fundamentals
- 1-day range
- $17.16$17.38
- Market cap
- $36.83B
- P/E (trailing)
- 20.57
- P/E (forward)
- 13.87
- EPS (trailing)
- $0.86
- Dividend yield
- 4.47%
- Beta
- 0.47
- Avg. volume
- 22.08M
- Ex-dividend date
- September 21, 2026
- Dividend pay date
- October 2, 2026
How Kenvue Inc. Common Stock Makes Money
Where the revenue actually goes — FY2025 annual results
Source: 10-K filed Feb 20, 2026 · via SEC EDGAR / Finnhub
Forecasts
12 analyst ratings
Kenvue Inc. Common Stock Competitors
Chosen by industry and closest market cap.
- KVUEKenvue Inc. Common Stock$18.91▲ 1.29%Market cap $36.83BP/E 20.57$14.02$20.13
- ELEstee Lauder Companies Inc. (The) Common Stock$104.54▼ 2.47%Market cap $30.93BP/E 205.30$66.22$121.64
- HLNHaleon plc American Depositary Shares (Each representing two Ordinary Shares)$10.13▲ 1.91%Market cap $44.67BP/E 19.62$317.9$416.1
- CHDChurch & Dwight Company Inc. Common Stock$104.53▲ 1.41%Market cap $24.52BP/E 32.23$81.33$106.04
- ELFe.l.f. Beauty Inc. Common Stock$113.54▼ 2.21%Market cap $5.49BP/E 106.33$48.82$141.5
- IPARInterparfums Inc. Common Stock$115.69▲ 0.50%Market cap $3.81BP/E 22.34$77.21$129.29
- COTYCoty Inc. Class A Common Stock$3.2▲ 0.31%Market cap $2.39BP/E —$1.82$4.43
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| KVUE Kenvue Inc. Common Stock | $36.83B | 20.57 | $18.91 | ▲ 1.29% | $14.02$20.13 |
| EL Estee Lauder Companies Inc. (The) Common Stock | $30.93B | 205.30 | $104.54 | ▼ 2.47% | $66.22$121.64 |
| HLN Haleon plc American Depositary Shares (Each representing two Ordinary Shares) | $44.67B | 19.62 | $10.13 | ▲ 1.91% | $317.9$416.1 |
| CHD Church & Dwight Company Inc. Common Stock | $24.52B | 32.23 | $104.53 | ▲ 1.41% | $81.33$106.04 |
| ELF e.l.f. Beauty Inc. Common Stock | $5.49B | 106.33 | $113.54 | ▼ 2.21% | $48.82$141.5 |
| IPAR Interparfums Inc. Common Stock | $3.81B | 22.34 | $115.69 | ▲ 0.50% | $77.21$129.29 |
| COTY Coty Inc. Class A Common Stock | $2.39B | — | $3.2 | ▲ 0.31% | $1.82$4.43 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- 'Kimberly-Clark Readies Bond Sale Ahead of Tylenol Maker Purchase' - Bloombergbenzinga · 10/16/2026
- Kenvue (KVUE), Why Is It Drawing Fresh Attention Now?Yahoo · 10/3/2026
- Why Medtronic’s $4 Billion MiniMed Exchange Offer Is Losing Its AllureYahoo · 10/2/2026
- Kenvue (KVUE) Stock Still Appears 41% Undervalued On Cash FlowYahoo · 10/1/2026
- Kimberly-Clark Announces Planned Executive Transitions and Updates to Post-Closing Leadership TeamYahoo · 10/1/2026
- LISTERINE® Launches Oral Care Counts This World Smile Day as Oral Disease Cases Rise to 3.73 BillionYahoo · 10/1/2026
- Kimberly Clark (KMB) Stock Could Be A Bargain After A 16% SlideYahoo · 10/1/2026
- Kimberly Clark (KMB) Launches Exchange Offers For Outstanding NotesYahoo · 9/30/2026
- Kimberly-Clark Keeps Raising Its Dividend. The Question Is Whether It Is Keeping Up With Your CostsYahoo · 9/30/2026
Insider Activity
Insider Actions →- ALLISON RICHARD E JR · September 28, 2026 · Grant1.3K
- Smith Jeffrey C · September 28, 2026 · Grant1.3K
- Meredith Stevens · September 25, 2026 · Option Exercise1.0K
- Meredith Stevens · September 25, 2026 · Option Exercise429
- Meredith Stevens · September 25, 2026 · Tax Withholding1.0K @ $17.81
- Meredith Stevens · September 25, 2026 · Tax Withholding429 @ $17.81
- Anindya Dasgupta · July 31, 2026 · Option Exercise16.4K
- ALLISON RICHARD E JR · June 29, 2026 · Grant1.4K
- Smith Jeffrey C · June 29, 2026 · Grant1.4K
- Heather Howlett · June 10, 2026 · Sale3.7K @ $18.11
- Mann Erica L · May 21, 2026 · Grant10.3K @ $17.46
- Seemantini Godbole · May 21, 2026 · Grant10.3K @ $17.46
- Hofstetter Sarah · May 21, 2026 · Grant10.3K @ $17.46
- Sneed Michael E · May 21, 2026 · Grant10.3K @ $17.46
- PAWLUS KATHLEEN M · May 21, 2026 · Grant10.3K @ $17.46
Institutional Ownership
March 31, 2026
- Total shares held
- 1.65B
- Total value held
- $27.16B
- Institutional holders
- 994
- Unknown145.30M
- Unknown135.09M
- Unknown124.42M
- Unknown119.57M
- Unknown56.60M
- Unknown51.27M
- Unknown49.74M
- Unknown49.21M
- Unknown32.40M
- Unknown27.31M
See the full, filterable feed with live charts on the MarketWall dashboard.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Kenvue Affected by Kimberly-Clark Bond Sale and Earnings Outlook
Kimberly-Clark is preparing a bond sale before its planned purchase of Kenvue, which could influence Kenvue's capital structure and investor perception. Analysts expect Kenvue's next quarterly earnings to reflect the impact of the acquisition and current market conditions. The company’s 2026 profit outlook remains unchanged, and consumer stocks overall were mixed in recent trading sessions.
Kenvue Affected by Kimberly-Clark Bond Sale and Earnings Outlook. Kimberly-Clark is preparing a bond sale before its planned purchase of Kenvue, which could influence Kenvue's capital structure and investor perception. Analysts expect Kenvue's next quarterly earnings to reflect the impact of the acquisition and current market conditions. The company’s 2026 profit outlook remains unchanged, and consumer stocks overall were mixed in recent trading sessions.